Clinical Research Directory
Browse clinical research sites, groups, and studies.
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Sponsor: Pierre Fabre Pharma GmbH
Summary
BERING-MELANOMA - designed as a prospective, longitudinal, non-interventional study - investigates real-world effectiveness, quality of life, safety and tolerability of encorafenib plus binimetinib in unresectable advanced or metastatic BRAF(Rapidly Accelerated Fibrosarcoma isoform B)-V600-mutant malignant melanoma after commercial availability of these two products in Germany, Austria and Switzerland. The study focusses on the documentation of the first and second line setting (i.e. after one line of prior checkpoint inhibition) by documenting patients treated according to the SmPC (Summary of Product Characteristics).
Official title: Encorafenib Plus Binimetinib in Patients With Locally Advanced, Unresectable or Metastatic BRAFV600-mutated Melanoma: a Multi-centric, Multinational, Prospective, Longitudinal, Non-interventional Study in Germany, Austria and Switzerland - BERING MELANOMA
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
750
Start Date
2019-10-17
Completion Date
2027-09
Last Updated
2021-01-19
Healthy Volunteers
No
Conditions
Interventions
Encorafenib
Observation of real-life treatment with encorafenib and binimetinib
Binimetinib
Observation of real-life treatment with encorafenib and binimetinib
Locations (59)
11
Graz, Austria
13
Innsbruck, Austria
14
Klagenfurt, Austria
10
Linz, Austria
3
Linz, Austria
12
Salzburg, Austria
22
Vienna, Austria
53
Vienna, Austria
23
Wiener Neustadt, Austria
45
Ahaus, Germany
8
Aschaffenburg, Germany
56
Augsburg, Germany
51
Berlin, Germany
27
Bremerhaven, Germany
1
Buxtehude, Germany
43
Chemnitz, Germany
34
Donauwörth, Germany
49
Dresden, Germany
47
Duisburg, Germany
40
Erfurt, Germany
20
Essen, Germany
9
Gera, Germany
28
Giessen, Germany
42
Goslar, Germany
59
Göttingen, Germany
19
Hamburg, Germany
21
Hanover, Germany
2
Heidelberg, Germany
33
Karlsruhe, Germany
39
Kiel, Germany
29
Landshut, Germany
44
Leipzig, Germany
30
Ludwigshafen, Germany
4
Lübeck, Germany
46
Magdeburg, Germany
15
Mainz, Germany
5
Mannheim, Germany
57
Marburg, Germany
6
Minden, Germany
31
München, Germany
7
München, Germany
16
Münster, Germany
35
Münster, Germany
18
Nuremberg, Germany
50
Regensburg, Germany
41
Schorndorf, Germany
17
Schwerin, Germany
48
Stolberg, Germany
55
Trier, Germany
54
Tübingen, Germany
32
Zwickau, Germany
52
Bellinzona, Canton Ticino, Switzerland
38
Aarau, Switzerland
37
Bern, Switzerland
24
Chur, Switzerland
36
Lausanne, Switzerland
58
Lucerne, Switzerland
26
Winterthur, Switzerland
25
Zurich, Switzerland